As medical software to treat, diagnose, cure or prevent disease becomes more developed, Korean regulators are increasingly approving clinical trials of such Software as a Medical Device (SaMD) technologies. Last year, the country’s Ministry of Food and Drug Safety approved 21 SaMD... Read More
Fueled in part by increased demand as a result of the COVID-19 pandemic, the market for medical devices in India is expected to ramp up over the next four years at a rapid clip, according to a report from data analytics firm... Read More
Chinese biotechnology firms have lagged behind their competitors for years in the use of artificial intelligence technologies. But increasingly, regulatory reforms are making it easier and cheaper for pharmaceutical companies in China to harness a vast trove of data collected from Chinese... Read More
Seeking to topple long-standing obstacles to drug innovation in Japan, Japanese pharmaceutical industry leaders have outlined a slate of steps they propose the government take to foster research and development of new products, trim regulations and approval times, and speed distribution. ... Read More
Advances in the use of artificial intelligence (AI) are fueling significant improvements in the field of radiology in Singapore, South Korea, and Australia, a new study has found. Eight in ten radiologists surveyed by health data firm Royal Phillips this year... Read More
Three major groups representing pharmaceutical companies doing business in Japan are pushing back publicly at what they call plans by regulators to impose onerous new price controls and regulations that would make it harder for them to bring much-needed drugs to market, ... Read More
With cancer a leading cause of death in Japan, the market for pharmaceuticals to treat tumors is expected to grow by 5% by 2023, and to represent one fifth of the market for pharmaceuticals by 2026. The prediction is part of a... Read More
Attracted by Shanghai government policies designed to encourage the development of the pharmaceutical industry, Western drug manufacturers are setting up shop in China’s financial hub. The biopharmaceutical firms are partnering with Chinese drug industry leaders, taking advantage of a reservoir of talented... Read More
With cancer a leading cause of death in Korea, the government plans to harness the power of big data to tackle the disease by increasing information sharing among healthcare institutions to bolster diagnosis, treatment, and research. At a meeting of the Korea... Read More
Contact us today for a free consultation with our Japan DMF expert. Currently the third-largest pharmaceutical market in the world, Japan presents many opportunities for foreign drug companies. Major factors such as a rising incidence of chronic diseases and a rapidly aging population... Read More